0.36
+0.0015(+0.41%)
Currency In USD
Address
9310 Athena Circle
LA Jolla, CA 92037
United States of America
Phone
347-897-5988
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
July 21, 2023
| Name | Title | Pay | Year Born |
| Dr. Sammy J. Farah M.B.A., Ph.D. | President, Chief Executive Officer & Director | 631,450 | 1973 |
| Ms. Saryah Azmat | Chief Operating Officer & Corporate Secretary | 426,900 | 1990 |
| Dr. Michael Fitch Ph.D. | Senior Vice President of Manufacturing | 0 | N/A |
| Dr. Ines Verdon M.D. | Senior Vice President of Clinical Development | 0 | N/A |
| Ms. Wendy Worcester CFA, CPA | Vice President, Principal Finance & Accounting Officer | 0 | N/A |
| Dr. David Stojdl Ph.D. | Senior Vice President of Research & Discovery | 0 | N/A |
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
